Amgen is delighted to announce the launch of the
PCSK9 Competitive Grant Program
, 这将为来自世界各地的研究人员提供一个机会来竞争高达 200,000 USD 旨在促进对 PCSK9 和动脉粥样硬化的理解的新颖研究提案.
The program is global in reach and is open to proposals from established and junior investigators*.
The deadline for applications is Friday, 可能 11, 2018 (11:59 pm US Pacific Time).
*Junior investigators should be within 5 years of completion of training
有兴趣了解当前的临床计划是否, 研究进展, 或新兴的治疗方法可能与您的情况相关?
仅教育和研究信息. 个人医疗决定应咨询合格的医疗保健专业人员.
